CRB-913

· Corbus Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CRB-913, covering 2026-03-18 to 2026-03-18. Get the full timeline:

Most recent: Clinical Trial Update: A 2-part, Phase 1b Clinical Study Designed to Evaluate the Safety, PK, and Efficacy of CRB-913 in Participants With Obesity [Phase 1]

See pricing